Myocardial Infarction Completed Phase 2 Trials for Atorvastatin (DB01076)

Also known as: Suspected myocardial infarction (MI) / Myocardial Infarct / MI / Myocardial Infarctions / Heart Attacks / Cardiac Infarct / Heart Attack / Myocardial Infarction (MI) / Cardiovascular Stroke / Stroke, Cardiovascular / Myocardial infarction (disorder) / Acute myocardial infarction / Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction / Attack heart (NOS) / Infarct myocardial / Right ventricular infarction / Attack coronary / Infarction of heart / Cardiac infarction, NOS / Attack - heart / Myocardial infarction, NOS / MI - myocardial infarction / Cardiac infarction / Heart attack, NOS / Infarction of heart, NOS / Myocardial infarction (& [acute]) or coronary thrombosis / Coronary artery thrombosis / Coronary artery thrombosis (disorder) / Thrombosis coronary / Coronary thrombosis / Occlusive coronary artery thrombus / Thrombosis - coronary / CT - Coronary thrombosis / (Myocardial infarction (& [acute] or [silent] or [cardiac rupture following])) or (coronary thrombosis)

IndicationStatusPhase
DBCOND0027900 (Myocardial Infarction)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00979758
Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial InfarctionTreatment
NCT01073800
Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically IllPrevention